Authors:
CIPRANDI G
RICCA V
PASSALACQUA G
TOSCA MA
MILANESE M
DANZIG M
SCORDAMAGLIA A
CANONICA GW
Citation: G. Ciprandi et al., LORATADINE REDUCES IN-VIVO NASAL EPITHELIAL ICAM-1 EXPRESSION, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1808-1808
Authors:
BAGNASCO M
MARIANI G
PASSALACQUA G
MOTTA C
BARTOLOMEI M
FALAGIANI P
MISTRELLO G
CANONICA GW
Citation: M. Bagnasco et al., ABSORPTION AND DISTRIBUTION KINETICS OF THE MAJOR PARIETARIA-JUDAICA ALLERGEN (PAR-J-1) ADMINISTERED BY NONINJECTABLE ROUTES IN HEALTHY-HUMAN BEINGS, Journal of allergy and clinical immunology, 100(1), 1997, pp. 122-129
Authors:
CIPRANDI G
PRONZATO C
PASSALACQUA G
RICCA V
GROGEN J
MELA GS
VARESE P
BERTOLINI C
BAGNASCO M
CANONICA GW
Citation: G. Ciprandi et al., TOPICAL AZELASTINE REDUCES EOSINOPHIL ACTIVATION AND INTERCELLULAR-ADHESION MOLECULE-1 EXPRESSION ON NASAL EPITHELIAL-CELLS - AN ANTIALLERGIC ACTIVITY (VOL 98, PG 1088, 1996), Journal of allergy and clinical immunology, 100(1), 1997, pp. 146-146
Citation: G. Passalacqua et Gw. Canonica, ALTERNATIVE ROUTES FOR ALLERGEN-SPECIFIC IMMUNOTHERAPY, Journal of investigational allergology & clinical immunology, 6(2), 1996, pp. 81-87
Authors:
PASSALACQUA G
BOUSQUET J
BACHERT C
CHURCH MK
BINDSLEVJENSEN C
NAGY L
SZEMERE P
DAVIES RJ
DURHAM SR
HORAK F
KONTOUFILI K
MALLING HJ
VANCAUWENBERGE P
CANONICA GW
Citation: G. Passalacqua et al., THE CLINICAL SAFETY OF H-1-RECEPTOR ANTAGONISTS - AN EAACI POSITION PAPER, Allergy, 51(10), 1996, pp. 666-675
Authors:
CIPRANDI G
PRONZATO C
PASSALACQUA G
RICCA V
BAGNASCO M
GROGEN J
MELA GS
CANONICA GW
Citation: G. Ciprandi et al., TOPICAL AZELASTINE REDUCES EOSINOPHIL ACTIVATION AND INTERCELLULAR-ADHESION MOLECULE-1 EXPRESSION ON NASAL EPITHELIAL-CELLS - AN ANTIALLERGIC ACTIVITY, Journal of allergy and clinical immunology, 98(6), 1996, pp. 1088-1096
Authors:
CANONICA GW
BAGNASCO M
PASSALACQUA G
MOTTA C
BARTOLOMEI M
MARIANI G
Citation: Gw. Canonica et al., KINETICS OF RADIOLABELED ALLERGEN ADMINISTERED BY SUBLINGUAL AND ORALROUTE, Journal of allergy and clinical immunology, 97(1), 1996, pp. 191-191
Authors:
PASSALACQUA G
ALBANO M
RICCIO A
PRONZATO C
FALAQIANI P
SCORDAMAGLIA A
CANONICA GW
Citation: G. Passalacqua et al., NASAL IMMUNOTHERAPY (NIT) TO PARIETARIA - FOLLOW-UP OF A DOUBLE-BLIND-STUDY, Journal of allergy and clinical immunology, 97(1), 1996, pp. 200-200
Authors:
PASSALACQUA G
ALBANO M
RUFFONI S
PRONZATO C
RICCO AM
DIBERARDINO L
SCORDAMAGLIA A
CANONICA GW
Citation: G. Passalacqua et al., NASAL IMMUNOTHERAPY TO PARIETARIA - EVIDENCE OF REDUCTION OF LOCAL ALLERGIC INFLAMMATION, American journal of respiratory and critical care medicine, 152(2), 1995, pp. 461-466
Authors:
BAGNASCO M
PASSALACQUA G
PRONZATO C
ALBANO M
TORRE G
SCORDAMAGLIA A
Citation: M. Bagnasco et al., FIBROUS INVASIVE (RIEDELS) THYROIDITIS WITH CRITICAL RESPONSE TO STEROID TREATMENT, Journal of endocrinological investigation, 18(4), 1995, pp. 305-307
Authors:
CANONICA GW
PASSALACQUA G
PRONZATO C
CORBETTA L
BAGNASCO M
Citation: Gw. Canonica et al., EFFECTIVE LONG-TERM ALPHA-INTERFERON TREATMENT FOR HYPEREOSINOPHILIC SYNDROME, Journal of allergy and clinical immunology, 96(1), 1995, pp. 131-133
Authors:
CIPRANDI G
BUSCAGLIA S
PESCE G
PASSALACQUA G
RIHOUX JP
BAGNASCO M
CANONICA GW
Citation: G. Ciprandi et al., CETIRIZINE REDUCES INFLAMMATORY CELL RECRUITMENT AND ICAM-1 (OR CD54)EXPRESSION ON CONJUNCTIVAL EPITHELIUM IN BOTH EARLY-PHASE AND LATE-PHASE REACTIONS AFTER ALLERGEN-SPECIFIC CHALLENGE, Journal of allergy and clinical immunology, 95(2), 1995, pp. 612-621
Authors:
PASSALACQUA G
ALBANO M
RUFFONI S
SCARICABAROZZI I
SCORDAMAGLIA A
CANONICA GW
Citation: G. Passalacqua et al., SAFETY OF NIMESULIDE AS ALTERNATIVE DRUG IN PATIENTS WITH ADVERSE DRUG-REACTIONS, Journal of allergy and clinical immunology, 95(1), 1995, pp. 288-288
Authors:
CIPRANDI G
PRONZATO C
RICCA V
PASSALACQUA G
BAGNASCO M
CANONICA GW
Citation: G. Ciprandi et al., ALLERGEN-SPECIFIC CHALLENGE INDUCES INTERCELLULAR-ADHESION MOLECULE-1(ICAM-1 OR CD54) ON NASAL EPITHELIAL-CELLS IN ALLERGIC SUBJECTS - RELATIONSHIPS WITH EARLY AND LATE INFLAMMATORY PHENOMENA, American journal of respiratory and critical care medicine, 150(6), 1994, pp. 1653-1659
Authors:
GIOVANE AL
BARDARE M
PASSALACQUA G
RUFFONI S
SCORDAMAGLIA A
GHEZZI E
CANONICA GW
Citation: Al. Giovane et al., A 3-YEAR DOUBLE-BLIND PLACEBO-CONTROLLED STUDY WITH SPECIFIC ORAL IMMUNOTHERAPY TO DERMATOPHAGOIDES - EVIDENCE OF SAFETY AND EFFICACY IN PEDIATRIC-PATIENTS, Clinical and experimental allergy, 24(1), 1994, pp. 53-59